ONCO Stock Chart & Stats
C$1.47
C$0.03(2.80%)
At close: 4:00 PM EST
C$1.47
C$0.03(2.80%)
Day’s Range― - ―
52-Week RangeC$1.45 - C$1.53
Previous CloseN/A
Volume353.06K
Average Volume (3M)47.16K
Market Cap
C$87.56M
Enterprise ValueN/A
Total Cash (Recent Filing)C$1.41M
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta0.66
Next Earnings
Aug 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding59,565,857
10 Day Avg. Volume42,021
30 Day Avg. Volume47,156
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ONCO FAQ
What was Onco-Innovations Ltd.’s price range in the past 12 months?
Onco-Innovations Ltd. lowest stock price was C$1.45 and its highest was C$1.53 in the past 12 months.
What is Onco-Innovations Ltd.’s market cap?
Onco-Innovations Ltd.’s market cap is C$87.56M.
When is Onco-Innovations Ltd.’s upcoming earnings report date?
Onco-Innovations Ltd.’s upcoming earnings report date is Aug 05, 2026 which is in 35 days.
How were Onco-Innovations Ltd.’s earnings last quarter?
Onco-Innovations Ltd. released its earnings results on Apr 07, 2026. The company reported -C$0.053 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.053.
Is Onco-Innovations Ltd. overvalued?
According to Wall Street analysts Onco-Innovations Ltd.’s price is currently Overvalued.
Does Onco-Innovations Ltd. pay dividends?
Onco-Innovations Ltd. does not currently pay dividends.
What is Onco-Innovations Ltd.’s EPS estimate?
Onco-Innovations Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Onco-Innovations Ltd. have?
Onco-Innovations Ltd. has 59,565,857 shares outstanding.
What happened to Onco-Innovations Ltd.’s price movement after its last earnings report?
Onco-Innovations Ltd. reported an EPS of -C$0.053 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Onco-Innovations Ltd.?
Currently, no hedge funds are holding shares in TSE:ONCO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Onco-Innovations Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
-351.83%
Trailing 12-Months
Asset Growth
-61.62%
Trailing 12-Months
Company Description
Onco-Innovations Ltd.
Onco-Innovations Ltd. is a Canadian biotech company, which engages in cancer research and treatment, specializing in oncology. Its product includes the ONC010 for cancer treatments. The company was founded on September 16, 2021 and is headquartered in Calgary, Canada.
Technical Analysis
Aptose Biosciences
―
Medicenna Therapeutics Corp
―
BriaCell Therapeutics
―
Fennec Pharmaceuticals
―
Defence Therapeutics
―
Options Prices
Currently, No data available
---







